[1] Mohan C, Adams S, Stanik V, et al. Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus. J Exp Med,1993, 177: 1367-1381. [2] 曾凡钦,陈宜芳,李伯有,等.系统性红斑狼疮患者血清DNA酶测定的临床意义.中华皮肤科杂志,1998,131:354-356. [3] Napirei M, Karsunky H, Zevnik B, et al. Features of systemic lupus erythematosus in DNase1-deficient mice. Nat Genet, 2000, 25:177-181. [4] Iida R, Yasuda T, Aoyama M, et al. The fifth allele of the human deoxyribonuclease I (DNase I) polymorphism. Electrophoresis, 1997,18: 1936-1939. [5] Yasutomo K, Horiuchi T, Kagami S, et al. Mutation of DNase1 in people with systemic lupus erythematosus. Nat Genet, 2001, 28:313-314. [6] 许蓓红,许德清,谢彦博.SLE患者PBMC表面的DNA受体及其临床意义.中华皮肤科杂志,1991,24:228-231. [7] Lachmann PJ. The in vivo destruction of antigen--a tool for probing and modulating an autoimmune response. Clin Exp Immunol, 1996,106: 187-189. [8] Simmonds M J, Heward JM, Kelly MA, et al. A nonsense mutation in exon 2 of the DNase I gene is not present in UK subjects with systemic lupus erythematosus and Graves' disease: Comment on the article by Rood et al. Arthritis Rheum, 2002, 46:3109-3110. [9] Balada E, Ordi-Ros J, Hernanz S, et al. DNase I mutation and systemic lupus erythematosus in a Spanish population: comment on the article by Tew et al. Arthritis Rheum, 2002, 46: 1974-1976. |